Stimcell Energetics (STME) Accumulated Depreciation & Amortization (2016)
Stimcell Energetics' quarterly Accumulated Depreciation & Amortization came in at $18510.0 in Q4 2016, up 2.77% quarter-over-quarter from $18011.0 in Q3 2016.
Stimcell Energetics has reported Accumulated Depreciation & Amortization for 1 years, with the latest figure at $18510.0 in Q4 2016.
- For the quarter ending Q4 2016, Accumulated Depreciation & Amortization changed N/A year-over-year to $18510.0; the trailing twelve-month figure through Nov 2016 stood at $18510.0 (changed N/A YoY), and the FY2016 full-year result was $20603.0, up 953.86% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2016 stood at $18510.0, up from $18011.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $20603.0 in Q2 2016, with the low at $9920.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2016 | 18,510.00 |
| Nov 30, 2016 | 18,510.00 |
| Aug 31, 2016 | 18,011.00 |
| Aug 31, 2016 | 18,011.00 |
| May 31, 2016 | 20,603.00 |
| May 31, 2016 | 20,603.00 |
| Feb 29, 2016 | 9,920.00 |
| Feb 29, 2016 | 9,920.00 |